Coagulation factor XIa Uses, Dosage, Side Effects and more

Coagulation factor XIa is under investigation in clinical trial NCT01701947 (HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency).

Attribute	Details
Trade Name	Coagulation factor XIa
Generic	Coagulation factor XIa
Coagulation factor XIa Other Names	Human coagulation factor XI
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph